https://www.uromedica-inc.com/news/lexington-man's-quality-of-life-restored-with-new-solution-to-prevent-prostate-incontinence 2024-06-03 https://www.uromedica-inc.com/news/there%E2%80%99s-a-new-solution-to-prevent-incontinence-after-prostate-surgery! 2024-04-30 https://www.uromedica-inc.com/news/dr.-michael-feloney-of-chi-health-on-omaha-everday 2024-03-22 https://www.uromedica-inc.com/news/eau-paris 2024-03-05 https://www.uromedica-inc.com/news/aua-san-antonio%2C-texas 2024-03-05 https://www.uromedica-inc.com/news/88th-annual-meeting-of-the-southeastern-section-of-the-aua%2C-inc. 2024-03-05 https://www.uromedica-inc.com/news/uromedica-at-smsna- 2023-09-11 https://www.uromedica-inc.com/news/uromedica-at-the-western-section-of-the-aua 2023-09-11 https://www.uromedica-inc.com/news/uromedica-at-urology-today 2023-09-11 https://www.uromedica-inc.com/news/uromedica-at-ncsaua 2023-09-11 https://www.uromedica-inc.com/news/uromedica-at-ics-2023 2023-09-11 https://www.uromedica-inc.com/news/uromedica-at-aua-2023 2023-09-11 https://www.uromedica-inc.com/news/uromedica-at-eau-2023 2023-09-11 https://www.uromedica-inc.com/news/uromedica-at-sufu-nashville-2023 2023-01-30 https://www.uromedica-inc.com/news/uromedica-at-aua-2022 2022-05-03 https://www.uromedica-inc.com/news/new-proact-paper%3A-bada-et-al 2022-05-03 https://www.uromedica-inc.com/news/new-cpt-i-codes-for-proact 2022-05-03 https://www.uromedica-inc.com/news/proact-receives-french-national-reimbursement 2022-05-03 https://www.uromedica-inc.com/news/uromedica-at-aua-2021 2022-05-03 https://www.uromedica-inc.com/news/first-patients-enrolled-in-act-trial 2022-05-03 https://www.uromedica-inc.com/news/act-clinical-trial- 2022-05-03 https://www.uromedica-inc.com/news/new-proact-surgical-video 2022-05-03 https://www.uromedica-inc.com/news/new-proact-animation 2022-05-03 https://www.uromedica-inc.com/news/new-proact-paper%3A-munier-et-al 2022-05-03 https://www.uromedica-inc.com/news/new-proact-paper%3A-larson-et-al 2022-05-03 https://www.uromedica-inc.com/news/new-proact-paper%3A-nash-et-al 2022-05-03 https://www.uromedica-inc.com/news/first-us-commercial-implant-of-proact 2022-05-03 https://www.uromedica-inc.com/news/launch-of-proact-and-reimbursement-coding 2022-05-03 https://www.uromedica-inc.com/news/french-randomized-trial-between-act-and-ams-800-aus 2022-05-03 https://www.uromedica-inc.com/news/new-proact-paper%3A-reuvers-et-al 2022-05-03 https://www.uromedica-inc.com/news/proact-pma-approved-by-usa-fda 2022-05-03